February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today ...

Immunic (IMUX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Faisal Khurshid from Leerink Partners reiterated a Buy rating on the ...

HB Wealth Management LLC bought a new position in Immunic, Inc. (NASDAQ:IMUX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...